Found 12 matching trials
Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.
PHASE3Subjects who completed the Double-blind Randomized Maintenance Phase (DBRMP...
Location
Multiple Locations
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
PHASE2This is an international, multicentre, parallel-group, randomised, double-b...
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
PHASE3To evaluate the efficacy of two different doses (5 and 10 g) of ZS orally a...
Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.
PHASE3It is hypothesized that ZS is more effective than placebo control (alternat...
Location
Multiple Locations
A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8
PHASE2The study is designed to determine if ZS 10g administered up to three times...
ZS Ph2/3 Dose-response Study in Japan
PHASE2To assess efficacy of 5 g three times daily (TID) and 10 g TID ZS versus pl...
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia
PHASE3To evaluate the efficacy of two different doses (5 and 10 g) of ZS orally a...
Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months
PHASE3The Open-Label Maintenance Study contains an Acute Phase, in which subjects...
Location
Multiple Locations
Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia
PHASE3The Open-Label Maintenance Study contains an Correction Phase, in which sub...
A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)
PHASE1This is a single center, inpatient, open label pharmacodynamic study to det...